Lineage Cell Therapeutics
LCTX
#7537
Rank
ยฃ0.30 B
Marketcap
ยฃ1.20
Share price
0.63%
Change (1 day)
283.31%
Change (1 year)

Earnings for Lineage Cell Therapeutics (LCTX)

Earnings in 2025 (TTM): -ยฃ15.53 Million

According to Lineage Cell Therapeutics 's latest financial reports the company's current earnings are ยฃ10.81 Million. In 2024 the company made an earning of -ยฃ16.28 Million, an increase over its 2023 earnings that were of -ยฃ18.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lineage Cell Therapeutics from 1992 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ15.53 Million-4.62%
2024 -ยฃ16.28 Million-13.16%
2023 -ยฃ18.74 Million9.83%
2022 -ยฃ17.07 Million-54.24%
2021 -ยฃ37.29 Million86.07%
2020 -ยฃ20.04 Million-31.97%
2019 -ยฃ29.46 Million-5.42%
2018 -ยฃ31.15 Million1.1%
2017 -ยฃ30.81 Million-31.06%
2016 -ยฃ44.68 Million-10.38%
2015 -ยฃ49.86 Million29.69%
2014 -ยฃ38.45 Million31.68%
2013 -ยฃ29.2 Million
2011 -ยฃ14.17 Million89.78%
2010 -ยฃ7.47 Million206.06%
2009 -ยฃ2.44 Million-0.58%
2008 -ยฃ2.46 Million164.89%
2007 -ยฃ0.93 Million-30.22%
2006 -ยฃ1.33 Million
2002 -ยฃ1.55 Million-41.04%
2001 -ยฃ2.62 Million-32.04%
2000 -ยฃ3.85 Million-11.85%
1999 -ยฃ4.37 Million
1997 -ยฃ2.81 Million12.12%
1996 -ยฃ2.51 Million106.25%
1995 -ยฃ1.22 Million-11.11%
1994 -ยฃ1.37 Million50%
1993 -ยฃ0.91 Million20%
1992 -ยฃ0.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-ยฃ0.12 Billion 627.71%๐Ÿ‡บ๐Ÿ‡ธ USA